March 7, 2003 -- Premature infants benefit from being treated at birth with recombinant human copper-zinc superoxide dismutase (r-h CuZnSOD), according to the results of a randomized trial ...

Original Article Published: 19 February 2009 Economic evaluation of recombinant human copper zinc superoxide dismutase administered at birth to premature infants J A McBride, R B Parad, J M Davis ...

Oxidative stress is counteracted by various cellular systems, including copper–zinc superoxide dismutase 1 (SOD1) and its activating chaperone, that is, the copper chaperone for SOD1 (CCS1 ...